Re: HDL Functionality
|
8
|
Resverlogix Corp.
|
May 06, 2019 05:50PM
|
Re: HDL Functionality
|
1
|
Resverlogix Corp.
|
May 09, 2019 04:44PM
|
Re: HDL Functionality
|
1
|
Resverlogix Corp.
|
May 09, 2019 06:34PM
|
Re: Heading for a big volume day?
|
1
|
Resverlogix Corp.
|
Jun 05, 2018 01:06PM
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
3
|
Resverlogix Corp.
|
Apr 12, 2021 07:00PM
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
4
|
Resverlogix Corp.
|
Apr 12, 2021 07:08PM
|
Re: Heavier than normal trading on the OTC for RVXCF
|
3
|
Resverlogix Corp.
|
Mar 15, 2017 06:25PM
|
Re: Heavier than normal trading on the OTC for RVXCF
|
5
|
Resverlogix Corp.
|
Mar 15, 2017 08:46PM
|
Re: Heavier than normal trading on the OTC for RVXCF
|
5
|
Resverlogix Corp.
|
Mar 16, 2017 10:53AM
|
Re: Heavier than normal trading on the OTC for RVXCF
|
2
|
Resverlogix Corp.
|
Mar 16, 2017 12:15PM
|
Re: Heavier than normal trading on the OTC for RVXCF
|
3
|
Resverlogix Corp.
|
Mar 16, 2017 03:55PM
|
Re: Heavier than normal trading on the OTC for RVXCF
|
3
|
Resverlogix Corp.
|
Mar 15, 2017 04:38PM
|
Re: Hello
|
5
|
Resverlogix Corp.
|
Feb 16, 2022 04:11PM
|
Re: Hepa Links up close to the max 10% in early trading
|
1
|
Resverlogix Corp.
|
Apr 30, 2024 01:44PM
|
Re: Hepalink
|
2
|
Resverlogix Corp.
|
Oct 15, 2021 09:10PM
|
Re: Hepalink
|
2
|
Resverlogix Corp.
|
Jun 13, 2022 01:18PM
|
Re: Hepalink
|
4
|
Resverlogix Corp.
|
Feb 22, 2020 02:40PM
|
Re: Hepalink IPO Document and what it says about RVX
|
2
|
Resverlogix Corp.
|
Jan 28, 2020 05:37PM
|
Re: Hepalink IPO Document and what it says about RVX
|
2
|
Resverlogix Corp.
|
Jan 28, 2020 05:39PM
|
Re: Hepalink IPO Document and what it says about RVX
|
3
|
Resverlogix Corp.
|
Jan 28, 2020 05:42PM
|